Health & Research Goals
Longevity Baseline
Base de Longevidad
High-Performance Stack
Select a vial or the total
Primary Description
Three pillars of longevity in one protocol: Epithalon activates telomerase for telomere maintenance. Thymosin Alpha-1 modulates T-cell immunity. GHK-Cu drives collagen synthesis and modulates over 4,000 tissue repair genes.
Demonstrated Effects
- Telomerase
- T-Cell
- Collagen
Proposed Mechanisms of Action
Combined Mechanism
Epithalon (Ala-Glu-Asp-Gly tetrapeptide) activates telomerase (hTERT) in fibroblasts, T-lymphocytes, and somatic cells — extending telomere length and reversing replicative senescence. It also restores pineal melatonin secretion and circadian rhythm, an independent aging pathway. Thymosin Alpha-1 reverses the thymic involution that drives immunosenescence: it matures naive T-cells into functional effector and memory populations, upregulates MHC class I/II, and normalizes NK cell activity — restoring the adaptive immune surveillance lost with aging. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) activates a gene expression reprogramming across 4,000+ genes: collagen and elastin synthesis, antioxidant enzyme upregulation (SOD, catalase), anti-inflammatory gene activation, and metalloproteinase balance — structurally reversing the hallmarks of tissue aging.
Stack Compounds
Research Evidence & Clinical Data
Research Profile
Epithalon activates telomerase for telomere maintenance. Thymosin Alpha-1 modulates T-cell immunity. GHK-Cu drives collagen synthesis and modulates 4,000+ repair genes. Three pillars: telomere integrity, immune function, tissue quality.
Safety Profile
Common Side Effects
- Monitor thyroid function every 3 months — Epithalon has thyroid-stimulating effects
- Comprehensive bloodwork (hormone panel, immune markers) recommended at baseline and every 3 months
- Tα1 may cause transient fatigue or mild immune activation symptoms in week 1
- Rotate injection sites for each compound to minimize local reactions
Contraindications
- Active malignancy (telomerase activation is contraindicated)
- Autoimmune thyroid disease
- Pregnancy
- Immunosuppressed patients post-transplant
Analytical Quality Assurance
Research Protocols
Dosing Protocols
Combined Research Protocol: Base de Longevidad
Sub-QMonitoring & Risk Management
Compound Stack Monitoring
For stacks and blends, refer to the individual compound monographs for each included ingredient for specific monitoring guidelines.